New antibiotics were underprescribed for hard-to-treat infections, study finds

Taking stock of the drug industry, from the lab to the medicine chest

April 19, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Melissa Brower/Centers for Disease Control and Prevention via AP STAT+ | New antibiotics were underprescribed for hard-to-treat infections, study finds Physicians turned to older, generic antibiotics for more than 40% of patients battling hard-to-treat pathogens. Study says cost may be a factor. By Ed Silverman Listen: A new obesity startup, an acquisition gone wrong, & the future of Teladoc This episode, we talk to Clive Meanwell about his new obesity startup, Metsera, and running head-to-head trials against Wegovy and Zepbound. By Allison DeAngelis and Adam Feuerstein STAT+ | Dana-Farber retracts string of studies in systematic review of data integrity Dana-Farber CEO Laurie Glimcher, a co-author, requested the retraction from a prominent journal after questions were raised about images. By Angus Chen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser